Alan Moore
Beaumont Hospital
23 Papers
163 Citations
Alan Moore is an academic researcher from Beaumont Hospital. The author has contributed to research in topics: Population & Stroke. The author has an hindex of 10, co-authored 20 publications. Previous affiliations of Alan Moore include Royal College of Surgeons in Ireland.
Chat about Author
Papers
Stroke Subtype Classification to Mechanism-Specific and Undetermined Categories by TOAST, A-S-C-O, and Causative Classification System Direct Comparison in the North Dublin Population Stroke Study
Michael Marnane,Caroline A. Duggan,Orla Sheehan,Aine Merwick,Niamh Hannon,Denis Curtin,Dawn Harris,Emma B. Williams,Gillian Horgan,Lorraine Kyne,Patricia M.E. McCormack,Joseph Duggan,Alan Moore,Gloria Crispino-O'Connell,Peter J. Kelly +14 more
TL;DR: Both CCS and ASCO schemes showed good-to-excellent agreement with TOAST, but each had specific characteristics compared with ToAST for subtype assignment and data retention.
230
Diagnostic Usefulness of the ABCD2 Score to Distinguish Transient Ischemic Attack and Minor Ischemic Stroke From Noncerebrovascular Events The North Dublin TIA Study
Orla Sheehan,Aine Merwick,Lisa A. Kelly,Niamh Hannon,Michael Marnane,Lorraine Kyne,Patricia M.E. McCormack,Joseph Duggan,Alan Moore,Joan T. Moroney,Leslie Daly,Dawn Harris,Gillian Horgan,Peter J. Kelly +13 more
TL;DR: The ABCD2 score had significant diagnostic usefulness for discrimination of true TIA and MIS from noncerebrovascular events, which may contribute to its predictive usefulness.
95
Falls and fractures 2 years after acute stroke: the North Dublin Population Stroke Study
Elizabeth Callaly,D. Ní Chróinín,Niamh Hannon,Orla Sheehan,Michael Marnane,Aine Merwick,Lisa A. Kelly,Gillian Horgan,Elizabeth Williams,D. Harris,David Williams,Alan Moore,Eamon Dolan,Sean Murphy,Peter J. Kelly,Joseph Duggan,Lorraine Kyne +16 more
TL;DR: Greater attention to falls risk, fall prevention strategies and bone health in the stroke population are required.
64
A novel neurotrophic therapeutic strategy for experimental stroke
Ludmila Belayev,Larissa Khoutorova,Karen L. Zhao,Allen W. Davidoff,Alan Moore,Steven C. Cramer +5 more
TL;DR: The current therapeutic strategy improved behavioral outcome and reduced lesion volume with a time window of 24 h after the onset of stroke, and could suggest a potential for translation into human stroke studies.
48
Improved Late Survival and Disability After Stroke With Therapeutic Anticoagulation for Atrial Fibrillation A Population Study
Niamh Hannon,Elizabeth Callaly,Alan Moore,Danielle Ní Chróinín,Orla Sheehan,Michael Marnane,Aine Merwick,Lorraine Kyne,Joseph Duggan,Patricia M.E. McCormack,Eamon Dolan,Gloria Crispino-O'Connell,Dawn Harris,Gillian Horgan,David Williams,Peter J. Kelly +15 more
TL;DR: In addition to improving short-term outcome in selected hospital-treated patient groups, therapeutic anticoagulation may provide important benefits for long-term stroke outcomes in unselected populations.
36